• Clinical science
  • Physician

Mitral regurgitation (Mitral valve regurgitation)

Summary

Mitral regurgitation (MR) refers to the leakage of blood from the left ventricle to the left atrium due to incomplete closure of the mitral valve. The most common causes are primary diseases of the valve (e.g., mitral valve prolapse), although damage may also result secondary to other heart conditions such as left ventricular dilation and myocardial infarction. Symptoms such as palpitations or dyspnea appear late in the course of chronic compensated MR in which cardiac output can still be maintained. In acute or chronic decompensated MR, pulmonary edema and pulmonary hypertension often cause dyspnea, coughing, jugular venous distention, and pitting edema. Echocardiography is the most important diagnostic tool and allows for assessment of severity. It may also be used for preoperative evaluation. Treatment options include surgical mitral valve repair or replacement and percutaneous reconstruction. Early intervention is favored in most cases of MR with evidence of left ventricular dysfunction, regardless of symptoms.

Etiology

References:[1][2][3][4]

Pathophysiology

References:[2][4]

Clinical features

References:[2]

Diagnostics

  • Auscultation
  • ECG
  • Chest X-ray
    • Posterior-anterior image
      • LV enlargement: laterally displaced left cardiac border
      • LA enlargement: straightening of the left cardiac border
      • Signs of pulmonary congestion in late stages of disease (see “X-ray findings in pulmonary congestion”)
    • Lateral image: Narrowing of the retrocardiac space
  • Echocardiography: most important diagnostic method for detecting and assessing valvular abnormalities
    • Valve apparatus (e.g., dimensions of valve opening area, calcification, rupture of the chordae tendineae) and mobility
    • LV and LA size and function
  • Coronary angiography: prior to surgical intervention

Myocardial infarction must be ruled out in patients presenting with acute MR!
References:[5][2][6][7]

Treatment

References:[2][3]

Complications

References:[2]

We list the most important complications. The selection is not exhaustive.

Acute management checklist

  • Initiate hemodynamic support for patients with unstable vitals.
  • Cardiology and cardiac surgery consult
  • Consider TEE
    • If TTE is inconclusive
    • For preoperative planning
  • Identify and treat the underlying cause (e.g., endocarditis, acute MI).
  • Consider definitive management options based on the underlying cause.
  • Continuous cardiac monitoring
  • Continuous pulse oximetry
  • Transfer to OR or ICU.
  • 1. Agabegi SS, Agabegi ED. Step-Up To Medicine. Baltimore, MD, USA: Wolters Kluwer Health; 2015.
  • 2. Hanson I. Mitral Regurgitation. In: Mitral Regurgitation. New York, NY: WebMD. http://emedicine.medscape.com/article/155618. Updated January 3, 2016. Accessed February 13, 2017.
  • 3. Collier P, Phelan D, Griffin BP. Mitral Valve Disease: Stenosis and Regurgitation. http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/mitral-valve-disease/. Updated August 1, 2014. Accessed February 13, 2017.
  • 4. Gaasch WH. Pathophysiology of chronic mitral regurgitation. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. http://www.uptodate.com/contents/pathophysiology-of-chronic-mitral-regurgitation. Last updated December 30, 2015. Accessed February 27, 2017.
  • 5. Le T, Bhushan V, Skelley N. First Aid for the USMLE Step 2 CK. McGraw-Hill Education; 2012.
  • 6. Otto CM. Clinical manifestations and diagnosis of chronic mitral regurgitation. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-chronic-mitral-regurgitation?source=machineLearning&search=echocardio+mitral+regurgitation&selectedTitle=2~150§ionRank=1&anchor=H10779670#H11. Last updated January 29, 2016. Accessed February 13, 2017.
  • 7. Tatco V, Gaillard F, et al. Left ventricular enlargement. https://radiopaedia.org/articles/left-ventricular-enlargement. Updated February 13, 2017. Accessed February 13, 2017.
  • Garg P, Swift AJ, Zhong L, et al. Assessment of mitral valve regurgitation by cardiovascular magnetic resonance imaging. Nat Rev Cardiol. 2019. doi: 10.1038/s41569-019-0305-z.
  • Bonow RO, O’Gara PT, Adams DH, et al. 2020 Focused Update of the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation. J Am Coll Cardiol. 2020. doi: 10.1016/j.jacc.2020.02.005.
  • Davey P, Sprigings D. Diagnosis and Treatment in Internal Medicine. Oxford University Press; 2018.
  • Klabunde R. Cardiovascular Physiology Concepts. Lippincott Williams & Wilkins; 2011.
  • Neskovic AN, Flachskampf FA. Stress Echocardiography. CRC Press; 2010.
  • Kramer CM. Role of Cardiac MR Imaging in Cardiomyopathies. J Nucl Med. 2015; 56(Supplement_4): pp. 39S–45S. doi: 10.2967/jnumed.114.142729.
  • Utsunomiya H, Hidaka T, Susawa H, et al. Exercise-Stress Echocardiography and Effort Intolerance in Asymptomatic/Minimally Symptomatic Patients With Degenerative Mitral Regurgitation Combined Invasive–Noninvasive Hemodynamic Monitoring. Circ Cardiovasc Imaging. 2018; 11(9). doi: 10.1161/circimaging.117.007282.
  • Krishna M, Zacharowski K. Principles of intra-aortic balloon pump counterpulsation. Continuing Education in Anaesthesia Critical Care & Pain. 2009; 9(1): pp. 24–28. doi: 10.1093/bjaceaccp/mkn051.
  • Feuchtner GM, Alkadhi H, Karlo C, et al. Cardiac CT Angiography for the Diagnosis of Mitral Valve Prolapse: Comparison with Echocardiography. Radiology. 2010; 254(2): pp. 374–383. doi: 10.1148/radiol.2541090393.
  • Solis J, McCarty D, Levine RA, et al. Mechanism of Decrease in Mitral Regurgitation After Cardiac Resynchronization Therapy. Circ Cardiovasc Imaging. 2009; 2(6): pp. 444–450. doi: 10.1161/circimaging.108.823732.
  • Roth BL. Drugs and Valvular Heart Disease. N Engl J Med. 2007; 356(1): pp. 6–9. doi: 10.1056/nejmp068265.
  • Webb, WR Higgins, CB. Thoracic Imaging: Pulmonary and Cardiovascular Radiology. Philadelphia: Lippincott Williams & Wilkins: p. 723.
  • Apostolakis EE, Baikoussis NG. Methods of estimation of mitral valve regurgitation for the cardiac surgeon. J Cardiothorac Surg. 2009; 4(1). doi: 10.1186/1749-8090-4-34.
  • Mick SL, Keshavamurthy S, Gillinov AM. Mitral valve repair versus replacement. Ann Cardiothorac Surg. 2015; 4(3): pp. 230–7. doi: 10.3978/j.issn.2225-319X.2015.03.01.
  • Borger MA, Mansour MC, Levine RA. Atrial Fibrillation and Mitral Valve Prolapse. J Am Coll Cardiol. 2019; 73(3): pp. 275–277. doi: 10.1016/j.jacc.2018.11.018.
  • Clavel M-A, Tribouilloy C, Vanoverschelde J-L, et al. Association of B-Type Natriuretic Peptide With Survival in Patients With Degenerative Mitral Regurgitation. J Am Coll Cardiol. 2016; 68(12): pp. 1297–1307. doi: 10.1016/j.jacc.2016.06.047.
  • Watanabe N. Acute mitral regurgitation. Heart. 2019; 105(9): pp. 671–677. doi: 10.1136/heartjnl-2018-313373.
  • Little SH. The Vena Contracta Area. JACC Cardiovasc Imaging. 2012; 5(7): pp. 677–680. doi: 10.1016/j.jcmg.2012.05.006.
  • El Sabbagh A, Reddy YNV, Nishimura RA. Mitral Valve Regurgitation in the Contemporary Era. JACC Cardiovasc Imaging. 2018; 11(4): pp. 628–643. doi: 10.1016/j.jcmg.2018.01.009.
  • Ahmed MI, McGiffin DC, O’Rourke RA, Dell’Italia LJ. Mitral Regurgitation. Curr Probl Cardiol. 2009; 34(3): pp. 93–136. doi: 10.1016/j.cpcardiol.2008.11.002.
  • Gaasch WH, Meyer TE. Left Ventricular Response to Mitral Regurgitation. Circulation. 2008; 118(22): pp. 2298–2303. doi: 10.1161/circulationaha.107.755942.
  • Nishimura RA et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary. J Am Coll Cardiol. 2014; 63(22): pp. 2438–2488. doi: 10.1016/j.jacc.2014.02.537.
  • Karen K. Stout, Edward D. Verrier. Acute Valvular Regurgitation. Circulation. 2009; 119(25): pp. 3232–3241. doi: 10.1161/circulationaha.108.782292.
  • Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017; 135(25). doi: 10.1161/cir.0000000000000503.
  • Domino FJ. The 5-Minute Clinical Consult 2014. Lippincott Williams & Wilkins; 2013.
last updated 03/27/2020
{{uncollapseSections(['9XaNZj', 'yXad0j', '_Xa50j', 'zXar0j', '0caeaj', 'bcaHaj', 'Xca9aj', 'nS17Zg0'])}}